用户名: 密码: 验证码:
六味地黄丸对KCl诱导PC12细胞钙超载损伤的保护作用
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:
     本实验通过不同浓度的KCl不同时间点作用于PC12细胞,观察细胞活力的变化,选取KCl诱导PC12细胞损伤模拟神经细胞钙超载的损伤;通过对PC12细胞形态及细胞存活率的观察,探讨六味地黄丸含药血清对PC12细胞的保护作用;通过对细胞内钙荧光强度变化的观察,观察六味地黄丸含药血清对细胞内钙离子浓度的影响;通过对CaMKII、CREB、BDNF mRNA和蛋白水平表达的测定,探讨六味地黄丸含药血清对Ca~(2+)-CaMKII-CREB-BDNF信号通路的影响。为六味地黄丸用于防治神经细胞内钙超载提供科学的实验数据与理论基础,初步探讨六味地黄丸对神经细胞保护作用的分子机制。
     材料与方法:
     按照随机数字法将雄性SD大鼠分为2组,即正常组、六味地黄丸组。六味地黄丸组,将生药浓度为0.75kg/L药液,按10mL/kg灌胃,每天2次,正常组给予同体积双蒸水灌胃,连续给药4天,第5天首次给药1.5h后腹主动脉取血,静置2h,2000r/min离心10min后分离血清。经56℃,30min灭活,0.22μm滤膜过滤灭菌,-20℃保存备用。取培养瓶中处于对数生长期的PC12细胞,经0.25%胰蛋白酶于37℃消化,加入含10%胎牛血清的DMEM完全培养液,细胞密度1×105/mL,37℃,5%CO2下继续培养12h后,细胞贴壁生长,换用无血清的DMEM培养液继续培养12h后用于实验。配置浓度为50、100、150、200mmol/L的KCl,分别损伤10、20、30min后采用MTT法检测PC12细胞的活性,依据时间短、损伤小但钙超载模型成功的原则选取KCl的浓度。将PC12细胞分为六组:(1)空白对照组:10%空白血清;(2)模型组:10%空白血清+150mmol/L KCl;(3)中药干预组:10%六味血清+150mmol/L KCl;(4)西药干预组:10%空白血清+尼莫地平10umol/L+150mmol/L KCl;(5)预干预模型组:10%空白血清(预干预48h)+150mmol/L KCl;(6)预干预中药组:10%六味血清(预干预48h)+150mmol/L KCl。(2)、(3)和(4)组是含有胎牛血清的DMEM中培养48小时后,PBS洗2遍后药物血清与KCl同时加入,作用20min后用PBS洗2遍后加入对应血清及药物继续培养6h;(5)和(6)组是预干预48h后加KCl,作用20min后用PBS洗2遍后加入无血清DMEM继续培养6h。倒置显微镜下观察各组细胞形态,MTT法测定细胞存活率,细胞上清液中LDH活性测定。各组细胞经Fluo-3的负载后激光共聚焦显微镜检测细胞内钙离子平均荧光强度。各组细胞内总RNA的提取和RT-PCR法检测CaMKII、CREB、BDNF的mRNA表达。各组细胞爬片经固定后,SABC法检测细胞CaMKII、CREB、BDNF的蛋白表达。收集细胞,提取各组细胞总蛋白,western blot法检测CaMKII、CREB、BDNF的蛋白表达。
     结果:
     1KCl诱导细胞损伤模型建立
     统计结果显示:与对照组比较,150mmol/L、200mmol/L的KCl作用20min后细胞活力明显性降低(P<0.05),100mmol/L、150mmol/L、200mmol/L的KCl作用30min细胞活力明显性降低(P<0.05)。
     2六味地黄丸含药血清对KCl诱导PC12细胞损伤的影响
     2.1形态学观察
     倒置显微镜下,空白对照组细胞呈梭形,胞间接触紧密,并伸出伪足,伪足有交错,增殖旺盛,折光度强;模型组、预干预模型组细胞伪足大部分消失,折光度减弱,部分细胞皱缩、变圆、脱落,漂浮于培养基中;中药干预组和西药干预组,细胞肿胀,少数折光度减弱,少数细胞脱落;预干预中药组细胞折光度强,细胞增殖旺盛。
     2.2KCl损伤后对各组细胞活力(MTT)的影响
     与空白对照组比较,模型组细胞存活率显著降低(P<0.01),预干预模型组、中药干预组和西药干预组细胞存活率明显降低(P<0.05);与模型组相比,中药干预组和西药干预组细胞存活率明显提高(P<0.05);与预干预模型组相比,预干预中药组细胞存活率显著提高(P<0.01)。
     2.3KCl损伤对各组细胞上清液中LDH活力的影响
     与空白对照组比较,模型组细胞上清液中LDH活力显著提高(P<0.01),预干预模型组、中药干预组和西药干预组细胞上清液中LDH活力明显提高(P<0.05);与模型组相比,中药干预组和西药干预组细上清液中LDH活力明显降低(P<0.05);与预干预模型组相比,预干预中药组细胞上清液中LDH活力明显降低(P<0.05)。
     3六味地黄丸含药血清对细胞内游离钙浓度的影响
     激光共聚焦观察细胞内钙荧光强度的变化,统计结果显示:静息时,预干预中药组细胞内钙离子平均荧光强度明显低于空白对照组、模型组、中药干预组、西药干预组、预干预模型组(P<0.05),其余各组间无显著性差异;动态时,与空白对照组相比,模型组、中药干预组、西药干预组、预干预模型组细胞内钙荧光强度显著性增高(P<0.01),与模型组相比,中药干预组细胞内钙荧光强度明显降低(P<0.05),西药干预组细胞内钙荧光强度显著性降低(P<0.01),与预干预模型组相比,预干预中药组细胞内钙荧光强度显著性降低(P<0.01),与中药干预组相比,预干预中药组细胞内钙荧光强度显著性降低(P<0.01);与静息时比较,动态时模型组、中药干预组、西药干预组、预干预模型组细胞内钙荧光强度显著性增高(P<0.01),动态时预干预中药组胞内钙荧光强度明显增高(P<0.05)。
     4六味地黄丸含药血清对信号通路中CaMKII、CREB、BDNF的影响
     4.1各组细胞CaMKII、CREB、BDNF mRNA表达的变化
     统计结果显示:与空白对照组相比,模型组、中药干预组、西药干预组、预干预模型组、预干预中药组的CaMKII mRNA表达显著性降低(P<0.01),与模型组相比,中药干预组、西药干预组的CaMKII mRNA表达显著性增高(P<0.01),预干预模型组相比,预干预中药组的CaMKII mRNA表达显著性增高(P<0.01);与空白对照组相比,模型组、中药干预组CREB mRNA表达显著性降低(P<0.01),西药干预组CREB mRNA表达明显降低(P<0.05),与模型组相比,中药干预组CREB mRNA表达明显增高(P<0.05),西药干预组CREB mRNA表达显著增高(P<0.01),与预干预模型组相比,预干预中药组CREB mRNA表达显著增高(P<0.01),与中药干预组相比,预干预中药组CREB mRNA表达明显增高(P<0.05);与空白对照组相比,模型组、预干预模型组的BDNF mRNA表达显著性降低(P<0.01),中药干预组、西药干预组的BDNF mRNA表达明显降低(P<0.05),与模型组相比,中药干预组BDNF mRNA表达明显增高(P<0.05),西药干预组BDNF mRNA表达显著增高(P<0.01),与预干预模型组相比,预干预中药组BDNF mRNA表达显著增高(P<0.01),与中药干预组相比,预干预中药组BDNF mRNA表达显著增高(P<0.01),与西药干预组相比,预干预中药组BDNFmRNA表达明显增高(P<0.05)。
     4.2各组细胞CaMKII、CREB、BDNF蛋白表达的变化
     4.2.1SABC免疫组化法检测统计结果
     统计结果显示:与空白对照组相比,模型组、中药干预组、西药干预组、预干预模型组CaMKII蛋白表达显著降低(P<0.01),与模型组相比,中药干预组、西药干预组CaMKII蛋白表达显著增高(P<0.01),预干预模型组相比,预干预中药组的CaMKII蛋白表达显著增高(P<0.01),与中药干预组相比,预干预中药组的CaMKII蛋白表达显著增高(P<0.01),与西药干预组相比,预干预中药组的CaMKII蛋白表达显著增高(P<0.01);与空白对照组相比,模型组、中药干预组、西药干预组、预干预模型组、预干预中药组的CREB蛋白表达显著降低(P<0.01),与模型组相比,中药干预组、西药干预组的CREB蛋白表达显著增高(P<0.01),与预干预模型组相比,预干预中药组的CREB蛋白表达显著增高(P<0.01),与中药干预组相比,预干预中药组的CREB蛋白表达显著增高(P<0.01);与空白对照组相比,模型组、中药干预组、西药干预组、预干预模型组BDNF蛋白表达显著降低(P<0.01),与模型组相比,中药干预组、西药干预组的BDNF蛋白表达显著增高(P<0.01),预干预模型组相比,预干预中药组的BDNF蛋白表达显著增高(P<0.01),与中药干预组相比,预干预中药组的BDNF蛋白表达明显增高(P<0.05),与西药干预组相比,预干预中药组的BDNF蛋白表达明显增高(P<0.05)。
     4.2.2western blot法检测统计结果
     统计结果显示:与空白对照组相比,模型组、中药干预组、西药干预组、预干预模型组CaMKII蛋白表达显著降低(P<0.01),与模型组相比,中药干预组、西药干预组的CaMKII蛋白表达显著增高(P<0.01),预干预模型组相比,预干预中药组的CaMKII蛋白表达显著增高(P<0.01),与中药干预组相比,预干预中药组的CaMKII蛋白表达显著增高(P<0.01),与西药干预组相比,预干预中药组的CaMKII蛋白表达显著增高(P<0.01);与空白对照组相比,模型组、预干预模型组CREB蛋白表达显著降低(P<0.01),中药干预组、西药干预组CREB蛋白表达明显降低(P<0.05),与模型组相比,中药干预组、西药干预组的CREB蛋白表达显著增高(P<0.01),与预干预模型组相比,预干预中药组的CREB蛋白表达显著增高(P<0.01),与中药干预组、西药干预组相比,预干预中药组的CREB蛋白表达明显增高(P<0.05);与空白对照组相比,模型组、中药干预组、西药干预组、预干预模型组BDNF蛋白表达显著降低(P<0.01),与模型组相比,中药干预组、西药干预组的BDNF蛋白表达显著增高(P<0.01),与预干预模型组相比,预干预中药组的BDNF蛋白表达显著增高(P<0.01),与中药干预组、西药干预组相比,预干预中药组的BDNF蛋白表达显著增高(P<0.01)。
     结论:
     1不同浓度的KCl不同时间点作用于PC12细胞后,随着KCl的浓度加大及作用时间延长,细胞活力逐渐减弱,即KCl对细胞的损伤程度呈剂量-时间依赖性。最终选取150mmol/LKCl作为细胞损伤浓度,模拟神经细胞钙超载损伤状态;
     2六味地黄丸含药血清可提高PC12细胞的活力;
     3六味地黄丸含药血清可明显降低细胞内钙离子浓度,维持和调节细胞内钙稳态;
     4六味地黄丸含药血清可显著提高信号通路中CaMKII、CREB、BDNF的mRNA和蛋白表达。
PurPose:
     This experiment was designed to observe the vitality of the PC12cells by differentconcentrations of KCl on different time points, in order to select the concentration and thetime points of KCl inducing PC12cell injury, and simulate nerve cells’ injury from calciumoverload; Through observation of PC12cell morphology and survival rate, the protectiveeffect of liu wei di huang pill contained serum was discussed; Through observation of thechange of the flow intensity of extracellular calcium, the intracellular calcium ionconcentration was measured in order to evaluate the influence of liu wei di huang pillcontained serum; By measuring the expressions of CaMKII, CREB and BDNF in both proteinand gene levels, the effects of liuwei dihuang pill contained serum on CaMKII-CREB-BDNF signaling pathway were discussed. At last, the experiment was also used to providescientific experimental data and theoretical basis for the prevention and treatment ofAlzheimer's disease with liuwei dihuang pill, and partly illustrate the molecular mechanism ofthe protective effect of liu wei di huang pills on nerve cells.
     Material and method:
     Male SD rats were randomly divided into2groups as the normal group and liuweidihuang pill group. Rats in liuwei dihuang pill group were gavaged twice with10mL/kgaqueous solution in0.75kg/L crude drug concentration, and the rats in normal group weregavaged with double volume evaporate water for4days, and on the5th day, abdominal aortablood was collected1.5h after the first dose, and the blood was centrifuged for10min at2000r/min to separate serum. After56℃,30min inactivating,0.22mu m filter membranefiltration sterilizating, the serum was saved at–20℃for later use. PC12cells in thelogarithmic phase taken from the culture flask were digested by0.25%trypsin at37℃, andadded DMEM containing10%fetal bovine serum, which were continually cultured for12hin the conditions of cell density of1x105/mL,37℃and5%CO2, and then the cells beganto grow adherent to the wall, after switching to serum-free DMEM, the cells were cultured for another12h in order to be used in the experiment. Preparing KCl with differentconcentrations of50,100,150,200mmol/L to injure the cells for10,20,30min respectively,the activity of PC12cells were determined by MTT method. The cells were divided into sixgroups:(1) the control group:10%normal serum;(2) model group:10%normal serum plus150mmol/L KCl;(3) traditional Chinese medicine(TCM) intervention group:10%LiuWeiserum+150mmol/L KCl;(4) western medicine intervention group:10%normal serum+10umol/L nimo+150mmol/L KCl;(5) pre-intervention model group:10%normal serum (pre-intervention48h)+150mmol/L KCl;(6) pre-intervention in Chinese traditionalmedicine(TCM) group:10%LiuWei serum (pre-intervention48h)+150mmol/L KCl.(2),(3) and (4) group were cultured in DMEM contained fetal bovine serum after48hours, andwashed by the PBS twice, and then the drug serum and KCl were added at the same time.20min later, with PBS washing twice, the cells were added corresponding serum and drugs toculture for another6h;(5) and (6) groups were added KCl after48h early intervention, and20min later, with PBS washing twice, the cells were added serum-free DMEM to culture foranother6h. The cell morphology of each groups was observed under inverted microscope,and the cells’ survival rate and LDH were determined by MTT method. After48h culturing,Fluo-3load and laser scanning confocal microscopy detected the changes of meanfluorescence intensity in intracellular calcium ion. The total RNA was extracted from eachgroup of cells, and mRNA expression of CaMK II, CREB, BDNF were measured by RT-PCR.After fixing of the cells climbing in each group, the protein expressions of CaMK II, CREB,BDNF were measured by SABC. The cells were collected, total proteins of cells in eachgroup were extracted, and the protein expression of CaMK II, CREB, and BDNF weremeasured by western blot.
     Results:
     1. Successful establishment of KCl induced cell injury modelStatistical results show:compared with the control group, there were significantly decreasedin cell vitality with150mmol/L and200mmol/L KCl in20min (P<0.05), and there weresignificantly decreased in cell vitality with100mmol/L,150mmol/L and200mmol/L KCl in30min (P<0.05).
     2. The influence of liu wei di huang pill contained serum on KCl-induced cell injury
     2.1Morphological observation: From an inverted microscope, the cells of the control groupappear fusiform, close intercellular contacts, and extend staggered pseudopodia, strongproliferation and diopter; model group, pre-intervention model group show that pseudopodsof cell disappear, decreased diopter, some of the cell rounded shrinkage and float off in themedium; some cells swell with decreased diopter, and some float off in TCM interventiongroup and western medicine intervention group. Cells in pre-intervention groups show strongproliferation and diopter.
     2.2The influence of KCl induced cells injury on cell vitality of every groups (MTT).Compared to control group, cell survival rate of model groups was decreased significantly(P<0.01), and cell survival rate of pre-intervention model group, TCM intervention group andwestern medicine intervention group were also significantly decreased (P<0.05); Compared tothe model group, cell survival rate of TCM intervention group and the western medicineintervention group was significantly increased (P<0.05); Compared to pre-intervention modelgroup, the cell survival rate of pre-Chinese Medicines intervention was significantly increased(P<0.05).
     2.3The influence of KCl injured cells on LDH activity. Compared to blank control group,LDH activity in supernatant of model group of cells was significantly increased (P<0.01), inpre-intervention model group, TCM intervention group and the western medicine interventiongroup cell LDH activity in supernatant was significantly increased (P<0.05); Compared to themodel group, the TCM intervention group and the western medicine intervention group, LDHactivity in supernatant was decreased significantly (P<0.05); Compared to thepre-intervention model group, pre-intervention in TCM group of cells LDH activity insupernatant was decreased significantly (P<0.05).
     3. The influence of liuwei dihuang pill contained serum on Intracellular free calciumconcentration of PC12cellsThe changes of extracellular calcium influx fluorescence intensity were observed by the laserconfocal microscope, and the statistical results showed that under quiescent condition, themean intracellular calciumion fluorescence intensity pre-intervention of TCM wassignificantly lowered (P<0.05) than the control group, model group, TCM intervention group, western medicine intervention group and pre-intervention model group. There was nosignificant difference among the other groups. Under dynamic condition, compared to thecontrol group, there were significantly increased in model group, TCM intervention group,western medicine intervention group,pre-intervention model group(P<0.01); Compared to themodel group, there was significantly decreased in TCM intervention group(P<0.05), thewestern medicine intervention group(P<0.01); Compared to the pre-intervention model group,pre-intervention in TCM group of the mean intracellular calciumion fluorescence intensitywas decreased significantly(P<0.01);Compared with TCM intervention group and the westernmedicine intervention group, pre-intervention TCM group was decreased significantly(P<0.01); Compared with quiescent condition, there was a significant increased (P<0.01) inmodel group, intervention group,western medicine intervention group,and pre-interventionmodel group, while pre-intervention TCM group has significant increased (P<0.05) underdynamic condition.
     4. The influence of liuwei dihuang pill contained serum on the signaling pathway of CaMK II,CREB, BDNF in each group
     4.1Variations in the cells gene expression of CaMK II CREB, the BDNF in each groupStatistical results showed:Compared with the control group, model group, TCM interventiongroup, western medicine intervention group, pre-intervention model group, pre-interventionTCM group expression of CaMK II mRNA had significantly decreased (P<0.01),comparedwith the model group, the expression of CaMK II mRNA in TCM intervention group andwestern medicine intervention group, had significantly increased (P<0.01), compared with thepre-intervention model group, the expression of CaMK II mRNA in pre-intervention TCMgroup had significantly increased (P<0.01); Compared with the control group, model group,TCM intervention group, the expression of CREB mRNA had significantly decreased(P<0.01), and expression of CREB mRNA in western medicine intervention group hadsignificantly decreased (P<0.05), compared with the model group, expression of CREBmRNA in TCM intervention group had significantly increased (P<0.05), and expression ofCREB mRNA in western medicine intervention group, pre-intervention TCM group hadsignificantly increased (P<0.01), compared with the pre-intervention model group, expressionof CREB mRNA in pre-intervention TCM group had significantly increased (P<0.01), compared with the TCM intervention group, expression of CREB mRNA in pre-interventionTCM group had significantly increased (P<0.05); Compared with the control group,expression of BDNF mRNA in model group and pre-intervention model group hadsignificantly decreased (P<0.01), and expression of BDNF mRNA in TCM intervention group,western medicine intervention group had significant decreased (P<0.05), compared with themodel group, the expression of BDNF mRNA in TCM intervention group had significantlyincreased (P<0.05), and expression of BDNF mRNA in western medicine intervention group,pre-intervention in TCM had significant increased (P<0.01), compared to pre-interventionmodel group, expression of BDNF mRNA in pre-intervention TCM group had significantlyincreased (P<0.01), and expression of BDNF mRNA in pre-intervention TCM group hadsignificantly increased compared with the TCM intervention group (P<0.05), and the westernmedicine intervention group (P<0.01).
     4.2Variation of protein expression of CaMK II, CREB and of BDNF in each group cells
     4.2.1statistical results of SABC immunohistochemical assayThe statistical results showed:Compared with the control group, protein expression of CaMKII in model group, intervention group, western medicine intervention group, pre-interventionmodel group had significantly decreased (P<0.01), compared with the model group, proteinexpression of CaMK II in TCM intervention group, western medicine intervention group hadsignificantly increased (P<0.01), compared with the pre-intervention model group, proteinexpression of CaMK II in pre-intervention TCM group had significantly increased (P<0.01),compared with the TCM intervention group, western medicine intervention group, proteinexpression of CaMKII in pre-intervention TCM group had significantly increased (P<0.01);Compared with the control group, protein expression of CREB in the model group, TCMintervention group, western medicine intervention group, pre-intervention model group,pre-intervention TCM group had significantly decreased (P<0.01), compared with the modelgroup, protein expression of CREB in the TCM intervention group, western medicineintervention group had significant increased (P<0.01), compared with the pre-interventionmodel group, protein expression of CREB in pre-intervention TCM group had significantlyincreased (P<0.01), compared to TCM intervention group, protein expression of CREB in thepre-intervention TCM group had significantly increased (P<0.01); Compared with the control group, protein expression of BDNF in model group, TCM intervention group, westernmedicine intervention group, and pre-intervention group had significant decreased (P<0.01),compared with the model group, protein expression of BDNF in TCM intervention group,western medicine intervention group had significantly increased(P<0.01), compared withpre-intervention model group, protein expression of BDNF in pre-intervention TCM grouphad significantly increased (P<0.01),compared with the TCM intervention group and westernmedicine intervention group, protein expression of CREB in pre-intervention TCM group hadsignificant increased (P<0.05).
     4.2.2Statistical results of western blot assayThe statistical results showed: compared with the control group, protein expression of CaMKII in model group, intervention group, western medicine intervention group, pre-interventionmodel group had significantly decreased (P<0.01), compared with the model group, proteinexpression of CaMKII in TCM intervention group, western medicine intervention group hadsignificantly increased(P<0.01), compared with the pre-intervention model group,proteinexpression of CaMKII in pre-intervention TCM group had significantly increased (P<0.01),compared with the TCM intervention group, the western medicine intervention group, proteinexpression of CaMKII had significantly increased in pre-intervention TCM group (P<0.01);compared with the control group, protein expression of CREB in model group andpre-intervention model group had significantly decreased (P<0.01), and TCM interventiongroup, western medicine intervention group (P<0.05), compared with the model group,protein expression of CREB in TCM intervention group, western medicine intervention group,pre-intervention TCM group had significantly increased (P<0.01), compared with thepre-intervention model group, protein expression of CREB in pre-intervention TCM grouphad significantly increased (P<0.01), compared with the TCM intervention group and westernmedicine intervention group, protein expression of CREB in pre-intervention TCM group hadsignificantly increased (P<0.05); Compared with the control group, protein expression ofBDNF in the model group, TCM intervention group, western medicine intervention group,pre-intervention model group had significantly decreased (P<0.01), compared with the modelgroup, protein expression of BDNF in TCM intervention group, western medicineintervention group had significantly increased, compared with the pre-intervention model group, protein expression of BDNF in pre-intervention TCM group had significantlyincreased (P<0.01), compared with the TCM intervention group and western medicineintervention group, protein expression of BDNF in pre-intervention TCM group had asignificantly increased (P<0.01).
     Conclusion:
     1. By different KCl concentrations and time points on PC12cells, with the increase of KClconcentration and lasting times, cell viability was gradually weakened. The KCl injured cellsshowed the dose–timeliness dependence. The final selection of150mmol/L KCl as theconcentration of cell injuries was used to simulate neural cell injury.
     2. Liu Wei Di Huang pill-contained serum could improve the vitality of PC12cells.
     3. Liu Wei Di Huang pill-contained serum could significantly reduce the influx ofextracellular calcium, maintain and regulate intracellular homeostasis of Ca~(2+)
     4. Liu Wei Di Huang pill contained serum could significantly improve gene and proteinexpression of CaMKII, CREB, BDNF.
引文
[1]宋博毅,李兴军.钙代谢障碍与老年性痴呆[J].华北煤炭医学院学报.2006,8(5):625-626.
    [2]伍吉云,邓志敏.钙信号与阿尔茨海默病的关系及其作用[J].井冈山大学学报(自然科学版).2010,31(4):107-109.
    [3]周金黄,刘干中,王建华,等.老年性痴呆的研究进展[M].中药药理与临床.第四册.北京军事医学科学出版社,1996.219-225.
    [4]周坤福,王明艳,赵凤鸣,等.六味地黄丸延缓衰老作用机理的实验研究[J].江苏中医.1999,20(1):44-45.
    [5]卿照前.六味地黄丸延缓老年痴呆症50例疗效观察[J].中国中医药科技.2007,16(5):373-374.
    [6] FerriC.P,PrinceM.,et al.Alzheimer's DiseaseInternational.Global prevalenceof dementia:aDelphiconsensusstudy[J].Lancet.2005,366(9503):2112-2117.
    [7]张振馨,ZahnerGE,RomanGC等.中国北京、西安、上海和成都地区痴呆业型患病率的研究[Jl.中国现代神经疾病杂志.2005,5(3):156-157.
    [8] BeydounM.A.,LhotskyA.,WangYF,FornoGD.,YangA,MetterE.J.,FerrucciL.,O'BrienR.,ZondermanA.B.,AssociationofAdiposityStatusandChangesinEarlytoMid-AdulthoodWithIncidenceofAlzheimer'sDisease[J].Am.J.Epidemiol.2008,168:1179一1189.
    [9]吴彦,孙建宁,石任兵等.黄连解毒汤有效部位对神经细胞内钙超载的作用及机制分析[J].中国中药杂志.2010,35(16):2166-2168.
    [10] MattsonLaFerlaFM,ChanSL,et al.Calcium signaling in the ER:its rolein neuronalplasticity and neurodegenerative disorders[J].TreudsNeurosci.2000,23:222-229.
    [11]顾清.钙的生理功能及代谢的研究进展[J].中国食品卫生杂志,2002,14(6):29-33.
    [12]高利平.钙超载与细胞损伤[J].四川医学.2004,25(9):1039-1041.
    [13] Poncer JC,Esteban JA,Malinow R.Multiple mechanisms for the potentiation of AMPAreceptor-mediated transmission by alpha-Ca2+/calmodulin-dependent proteinkinaseⅡ[J].J Neurosci,2002,22(11):4406-4411.
    [14] Hsu KS,Huang CC,Ling YC,et al.Alterations in the balance of protein kinase andphosphatase activities and age-related impairments of synaptic transmission andlong-term potentiation[J].Hippocampus.2002,12(6):787-802.
    [15]王洪权.阿尔茨海默病中钙调节障碍[J].国外医学医学地理分册.2008,29(1):4-8.
    [16] Lopez JR,Lyckman A,Oddo S, et al.Increased intraneuronal resting [Ca2+]i in adultAlzheimer's disease mice[J].Neurochem.2008,105:262-271.
    [17] Ferreiro E,Oliveira CR,Pereira C,et al.Involvement of endoplasmic reticulum Ca2+release through ryanodine and inositol1,4,5-triphosphate receptors in the neurotoxiceffects induced by the amyloid-beta peptide[J].Neurosci Res.2004,76:872–880.
    [18] Ilya Bezprozvanny, Mark P Mattson. Neuronal calcium mishandling and thepathogenesis of Alzheimer’s disease[J].Cell.2008,31:454-463.
    [19] Michael Berridge.Elementary and global aspect s of calcium signal ling [J].Journal ofPhysiology.1997,499(2):291.
    [20] Michael J Berridge.Capacitative calcium entry[J].Biochem.J.1995,312:1.
    [21]孔庆胜.胞内钙信号系统的研究进展[J].济宁医学院学报.2000,23(3):86-87.
    [22]王羽,董志.钙离子拮抗剂治疗阿尔茨海默氏病的现状[J].中国药业.2003,12(12):31-32.
    [23]孙平,华茜,李澎涛等.神经元钙稳态失衡在阿尔茨海默病发病中的进展[J].现代生物医学进展.2009,9(6):1183-1185.
    [24] SelkoeDJ.Alzheimer'sdisease:genes,protein,and therapy[J].PhysiolRev.2001,81(2):741-766.
    [25] Demuro A,Mina E,Kayed R,et al.Calcium dysregulation and membrane disruptionas a ubiquitous neurotoxic mechanism of soluble amyloid oligomers[J]. J BiolChem.2005,280:17294-17300.
    [26]周明华,陈思颖,李美芳等.细胞周期与细胞凋亡[J].生理科学进展.1996,27:319.
    [27] Ho,R.,Ortiz,D.,andShea,T.B.Amyloid-promotes calcium influx and neurodegeneration via stimulation of Lvoltage sensitive calcium channels rather than NMDA channels incultured neurons[J].AlzheimersDis.2001,3:479-483.
    [28] Liu J, Liu MC, Wang KK. Calpain in the CNS: from synaptic function toneurotoxicity[J].Sci Signal.2008,1(14):re1.
    [29]高路,王超伟,胡为民.尼莫地平对AD大鼠脑组织NO的影响[J].中国现代医生基础研究.2010,48(7):5-6.
    [30] Lee G, Pollard HB, Arispe N. Annexin5and apolipoprotein E2protectagainstAlzheimer’s amyloid-β-peptide cytotoxicity by competitive inhibition at acommon phosphatidylserine interaction site[J].Peptides.2002,23:1249-1263.
    [31]许飞,程灶火,杨敏.Tau蛋白、Aβ蛋白与阿尔茨海默病的关系及其作用[J].实用临床医药杂志.2008,12(3):118-120.
    [32] S Duan,IM Cooke.Selective inhibition of transient K+current by La3+in crabpeptide-secretory neurons[J].J Neurophysiol.1999,81:1848-1855.
    [33] Xu TL,Dong XP,Wang DS. N-methyl-D-aspartate enhancement of the glycineresponse in the rat sacral dorsal commissural neurons[J].Eur J Neurosci.2000,12:1647-1653.
    [34] Smirnov SV, Aaronson PI. Ca2+currents in single myocytes from human mesentericarteries:evidence for a physiological role of L-type channels[J].J Physiol.1992,457:455-475.
    [35] LaFerla FM.Calcium dyshom eostasis and intracellular signaling in Alzheimer’sdisease[J].Nat Rev Neurosci.2002,3(11):862-872.
    [36] YooAS,ChengI,ChungS,etal.Presenilin-mediated modulation of capacitativecalcium entry[J].Neurou.2000,27:561-572.
    [37] Green KN,Demuro A,Akbari Y,et al.SERCA pump activity is physiologicallyregulated by presenilin and regulates amyloidβproduction[J].J Cell Biol.2008,181(2):1107-1116.
    [38]赵春雷.阿尔茨海默氏症病理新发现-患者体内突变基因可能起重要作用[J].世界科学.2009,12:35.
    [39] Cheng KH,Shineman D,Foskett J K,et al.Mechanism of Ca2+disruption in Alzheimer'sdisease by presenilin regulation of InsP3receptor channel gating [J].Neuron.2008,58(6):871-883.
    [40] Stutzmann,GE,etal.Enhance dryanodine receptor recruitment contributes to Ca2+disruptions in young,adult,and aged Alzheimer's disease mice[J].JNeurosci.2006,26(19):5180-5189.
    [41] Yang,YandD,CxCook.Presenilin-1deficiency impairs glutamate-evokedintracellularcalcium responses in neurons[J].Neuroscience.2004,124(3):501-505.
    [42] Zatti,Cz,et al.Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgiapparatus calcium levels[J].CellCalcium.2006,39(6):539-550.
    [43] Herms,J.et al.Capacitive calciumentryis directly attenuated by mutant presenilin-1,independent of the expression of the amyloid precursor protein[J].JBiolChem.2003,278(4):2484-2489.
    [44] Rovira C,Arbez N,Mariani J,et al.Abeta(25-35) and Abeta(1-40) act on differentcalcium channels in CA1hippocampal neurons[J]. Biochem Biophys ResCommun.2002,296:1317-1321.
    [45] MacManus A,Ramsden M,Murray M,et al.Enancement of45Ca2+influx andvoltage-dependent Ca2+channel activity by β-amyloid (1-40) in rat cotical synaptosomesand cultured cortical neurons. Modulation by the proinflamatory cvtokineinterleukin-1beta[J].J Biol Chem.2000,275:4713–4718.
    [46] Nelson,O,et al.Familial Alzheimer disease-linked mutations specifically disruptCa2+leak function of presenilin1[J].JClinInvest.2007,117(5):1230-1239.
    [47] NakaiM,KawataT,TaniguchiT,et al.Expressing if apolipoprotein Em RNA in rat microglia[J].Neuroscilett.1996,211(1):41-44.
    [48] Foster TC.Calcium homeostasis and modulation of synaptic plasticity in the agedbrain[J].Aging Cell.2007,6(3):319-25.
    [49]吕佩源.钙信号系统与学习和记忆[J].国外医学神经病学神经外科学分册.2004,31(2):141-143.
    [50] Remondes M,Schuman EM.Molecular mechanisms contributing to long-lastingsynaptic plasticity at the temporoammonic-CAI synapse[J].Learn Mem.2003,10(4):247-252.
    [51] Jouvenceau A,Billard JM,Haditsch U,et al.Different phosphatase-dependentmechanisms mediate long-term depression and depotentiation of long-term potentiationin mouse hippocampal CAI area[J].Eur J Neurosci.2003,18(5):1279-1285.
    [52] Okada T,Yamada N,Tsuzuki K,et al. long-term potentiation in the hippocampal CAIarea and dentate gyrus plays different roles in spatial learning[J].Eur J Neurosci.2003,17(2):341-349.
    [53] Raymongd CR,Ireland DR,Abraham WC.NMDA receptor regulation by amyloid-betadoes not account for its inhibition of LTP in rat hippocampus[J].Brain Res.2003,968(2):263-272.
    [54]于玮,苏兴利.钙离子和神经系统环路的整合作用[J].国外医学医学地理分册.2008,29(1):9-13.
    [55] Verkhratsky A. Calciumions and integration in neural circuits[J]. Acta Physiol(Oxf).2006,187(3):357-369.
    [56] Johnson CM,Hill CS, Chawla S,et al. Calcium controls gene expression via threedistinct pathways that can function independently of the Ras/mitogen-activated proteinkinases (ERKs) signaling cascade[J].J Neurosci.1977,17(16):6189-6202.
    [57] Jessen U,Novitskaya V,Pedersen N,et al.The transcription factors CREB and c-Fosplay key roles in NCAM-mediated neuritogenesis in PC12-E2cells[J]. JNeurochem.2001,79(6):1149-1160.
    [58]孙洲,龚瑜,孙圣刚钙超载对PC12细胞活性及p-CREB表达的影响[J].武汉大学学报(医学版).2011,32(3):284-286.
    [59] Fourcaudot E,Gambino F,Casassus G,et al.L-type volt-age-dependent Ca2+channelsmediate expression of presynaptic LTP in amygdala[J].Nat Neurosci.2009,12(9):1093-1095.
    [60] Wei F,Qiu CS,Liauw J, et al.Calcium calmodul independent protein kinase IV isrequired for fear memory[J].Nat Neurosci.2002,5(6):573-579.
    [61] KINGSBURYT J,KRUEGER BK.Ca2+,CREB and kruppe:lanovel KLF7-bindingelement conserved inmouse and human TRKB promoters is required forCREB-dependent transcription [J]. MolCell Neurosc.2007,35(3):447-455.
    [62]王洪欣.中药有效成分治疗老年痴呆的作用机制研究进展[J].山东中医杂志.2011,30(7):525-527.
    [63] Bezprozvanny I.Calcium signaling and neurodegenerative diseases[J].Trends MolMed.2009,15(3):89-100.
    [64]陈艳杏.阿尔茨海默病中的钙紊乱机制研究进展[J].国际神经病学神经外科学杂志.2009,36(5):441-444.
    [65] López-Arrieta JM, Birks J.Nimodipine for primary degenerative,mixed and vasculardementia[J].Cochrane Database Syst Rev.2002,(3):CD000147.
    [66]苏芮,韩振蕴,范吉平.阿尔茨海默病中医病因病机探讨[J].中华中医药杂志.2010,25(5):743-744.
    [67]李宝丽,唐方.老年痴呆从肾虚论治探讨[J].山西中医.2006,22(2):1-3.
    [68]安红梅,胡兵,靳淼,等.顾明昌教授从虚论治神经精神系统疾病经验[J].中国中医急症.2006,15(10):1119-1120.
    [69]孙西庆.从脾虚血瘀探讨老年痴呆的发生[J].中国中医药信息杂志.2012,19(4):92-94.
    [70]王灵俊.从肾虚痰瘀论治老年性痴呆[J].长春中医药大学学报.2011,27(3):392-393.
    [71]王永炎,尹颖辉.老年性痴呆辨治[J].中国医药学报.1994,9(2):49-51.
    [72]张伯礼,王晓辉.祖国医学对老年性痴呆的认识和治疗策略[J].中华老年多器官疾病杂志.2007,6(1):9-11.
    [73]隋华,刘晓亭,战丽彬.阴虚在老年期痴呆中的作用[J].中医药学刊.2005,23(6):1090-1091.
    [74]于梅,李连涛.肝气郁与老年期痴呆病相关性的理论探讨[J].江西中医药.2007,38(298):17-18.
    [75]常富业,张云岭,王永炎等.中医药醒脑散治疗老年性痴呆的临床研究[J].天津中医药.2008,25(5):367-368.
    [76]刘丽坤,王文彩.老年性痴呆的病机治则当议[J].中医药信息.1992,4(2):3-5.
    [77]王昌俊.中医对脑血管性痴呆的认识[J].陕西中医.1992,13(4):164-165.
    [78]傅仁杰.老年呆病的诊断、辨证分型及疗效评定标准(讨论稿)[J].中医杂志.1991,32(2):56.
    [79]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:91-98.
    [80]杨济民.老年性痴呆的中医论治[J].中医药研究.2001,17(2):58-59.
    [81]吴继全.傅仁杰教授治疗老年性痴呆经验摭拾[J].实用中医内科杂志.2007,21(5):14-15.
    [82]卢灿辉.卢永兵主任师治疗老年性痴呆经验介绍[J].新中医.2008,40(1):15-16.
    [83]郝艳鹏,张悦,刘煜敏,等.六味地黄丸含药血清对HK-2细胞对TGF-/Smad信号通路的影响[J].中国病理生理杂志.2011,27(1):149-152.
    [84]刘德军.六味地黄丸现代研究与应用[M].北京:人民卫生出版社,2005:1-2.
    [85]李方军.牡丹皮化学成分及药理作用研究进展[J].安徽医药.2004,8(1):9-10.
    [86]吕少启.六味地黄汤加味治疗老年性痴呆病例小结[J].甘肃中医.1999.12(2):12.
    [87]卿照前.六味地黄丸延缓老年痴呆症50例疗效观察[J].中国中医药科技,2007,16(5);373-384.
    [88]周建政.张永祥.周金黄.六味地黄汤对快速老化模型小鼠(SAM)学习记忆能力的改善作用.中国实验方剂学杂志.1998,5(4):29-33.
    [89]杨胜.张永祥.六味地黄汤含药血清对大鼠海马神经元电压门控离子通道的影响[J].中药药理与临床.2002,18(4):1-2.
    [90]娄淑杰.王晨光.黄秀英.高钾离子引起PC12细胞内游离Ca2+浓度升高的机制第二军医大学学报.1998,19(4):343-346.
    [91] Osuga S,Hogan MJ.In vivo uptake of[3h] nimodipine in focal cerebral ischemiamodulation by hyperglycemia[J].J Cereb Blood Flow Metab.1997,17(10):1057.
    [92] Mild LN,Mild LH,Dempsey,et al.Delayed treatment with nimodipine improves cerebral blood flow after complete cerebral,ischemia in the dog[J].J Cereb Blood FlowMetab.1986,6:332.
    [93]王英兰,张建平,杨冬梓,等.尼莫地平对生长受限胎鼠脑组织形态学及神经细胞凋亡率的影响[J].咸宁学院学报(医学版),2006,20(4):291.
    [94] Koike T,Mart in DP,Johns on EM.Role of Ca2+determine nerve growth fact ordependence of sympathetic ganglion cells[J].Proc Natl Acad Sci USA,1989,86:6421~6425.
    [95]王红梅,宋彩梅,刘新民,等.六味地黄丸对肾虚型老年痴呆动物模型的改善作用[J]中国实验方剂学杂志.2012,18(5):112-114.
    [96]杨胜,张永祥.六味地黄汤含药血清对大鼠海马神经元电压门控离子通道的影响[J].中药药理与临床.2002,18(4):1-2.
    [97]赵彩霞郑延松.细胞内游离钙检测方法进展.国外医学临床生物化学与检验学分册.2001,22(2):71-72.
    [98]黄晓瑾,刘伟芳,夏淋霞,等.中药钙拮抗剂的研究概况[J]中医杂志,2011,52(20):1789.
    [99]胡慧,王平,孔明望,等.补肾化痰方药对阿尔茨海默病模型大鼠脑组织钙/钙调素依赖的蛋白激酶Ⅱ-α活性的影响[J].中华中医药杂志.2010,25(5):786-788.
    [100] Jayanthi L D,Wilson J J,Montalvo J,et al.Differential regulation of mammalianbrain-specific praline transporter by calcium and calcium dependent protein kinasesl[J]. Br J Pharmacol.2000,129(3):465.
    [101] Chen G,Greengard P,Yah Z.Potentiation of NMAD receptor currents by dopamine D1receptorsin prefrontal coaex[J].Proc Natl Acad Sci USA.2004,101(8):2596.
    [102]张君,于嘉屏,曹雪涛.钙离子/钙调素依赖性蛋白激酶-Ⅱ及其抑制剂[J].国外医学临床生物化学与检验学分册.2002,23(4):237-239.
    [103]熊果,马康华.cAMP反应元件结合蛋白(CREB)与细胞凋亡[J].基础医学与临床.2011,31:328-330.
    [104] Kortaro T,Shigeru N,Eiichiro N,et al.Persistent CREB phosphorylation withprotection of Hippocampal CA1pyramidal neurons following temporary occlusion ofthe middle cerebral artery in rat [J].Exp Neurol,2000;16(2):462-471.
    [105] Bonni A,Bruunet A,West AE,et al.Cell survival promoted by the RAS-MAPKSignaling pathway by transcription dependent and independent mechanisms[J].Science,1999;286(5443):1358-1362.
    [106]葛军,张玉,郑增长,黄延旺,宋红生.CREB转录因子及其磷酸化信号通路的研究进展[J].安徽农业科学.2010,38(30):6769-16771.
    [107] Feng PF,Guan Z W,YangXP,et al.Impairments of ERK signal transduction in thebrain in a rat model of depression induced by neonatal exposure ofclomipramine[J].Brain Res.2003,991:195-205.
    [108] Mizuo M,Yamada K,Maekawa N,et al.CREB phosphorylation as a molecular markerof memory processing in the hippocampus for spatial learning[J]. Behav BrainRes.2002,133,135-141.
    [109] Pittenger C,Fasano S,Mazzocch-i Jones D,et al.Impaired bidirectinal synapticplasticity and procedural memory formation in striatum-specific cAMP responseelement-binding protein-deficient mice [J].Neurosci,2006,26(10):2808-2813.
    [110] Bright well JJ,Gallag her M,Co lombo PJ.Hippocampal CREB1but not CREB isdecreased in aged rats with spatial memory impairments[J].Neurobiol Learn Mem,2004,81(1):19-26.
    [111] Poo MM.Neurotrophins as synaptic modulators [J].Nat RevNeurosci,2001,2(1):24-32.
    [112] Yamada K,Mizuno M,Nabeshima T.Role for brain-derived neurotrophic factor inlearning and memory[J].Life Sci,2002,70(7):735-44.
    [113] Labelle C, Leclerc N. Exogenous BDNF, NT-3and NT-4differentially regulateneurite outgrowth in cultured hippocampal neurons[J].Brain Res Dev Brain Res,2000,123(1):1-11.
    [114]宋莉莉.脑源性神经营养因子与阿尔茨海默病[J].国外医学神经病学神经外科学分册.2004,31(5):478-480..
    [115] Connor B, Young D,Yan Q,et al. Brain-derived neurotrophic factor is reduced inAlzheimer's disease [J].Brain Res Mol Brain Res,1997,49(1-2):71-81.
    [116] Michalski B,Fahnestock M.Pro-brain-derived neurotrophic factor is decreased inparietal cortex in Alzheimer’s disease [J].Brain Res Mol Brain Res.2003,111(1-2):148-154.
    [117] Egleton RD,Davis TP.Bioavailability and transport of peptides and peptide drugs intothe brain[J].Peptides,1997,18(9):1431-9.
    [118] Holsinger RM, Schnarr J, Henry P, et al. Quantitation of BDNF mRNA in humanparietal cortex by competitive reverse transcription-polymerase chain reaction:decreased levels in Alzheimer's disease[J].BrainResMolBrainRes,2000,76(2):347-54.
    [119] Messaoudi E,Barsen K,Srebro B,et al.Acute int rahippocampal in fusion of BDNFinduces lasting potentiation of synaptic transmission in the rat dentate gyrus[J].JNeurophysiol,1998,79(1):496-499.
    [120]李燕华,李吕力,王铁建,等.大鼠脑缺血后P-CaMKⅡ的表达与Ca2+浓度的关系[J].中国急救医学.2006,26(6):436.
    [121]黄理钧,龚俊华,梁烨等.益智健脑颗粒对AD模型大鼠学习记忆能力及海马神经元BDNF表达的影响[J].中国行为医学科学.2006,15(9):780-782.
    [122] KunugiH,U eki A,Otsuka M,et al.A novel polymorphism of the brain-derivedneurotrophic factor(BDNF) gene associated with late-onset Alzheimer’sdisease[J].Mol Psychiatry.2001,6:83-86.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700